ATE237139T1 - Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten - Google Patents
Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheitenInfo
- Publication number
- ATE237139T1 ATE237139T1 AT96918399T AT96918399T ATE237139T1 AT E237139 T1 ATE237139 T1 AT E237139T1 AT 96918399 T AT96918399 T AT 96918399T AT 96918399 T AT96918399 T AT 96918399T AT E237139 T1 ATE237139 T1 AT E237139T1
- Authority
- AT
- Austria
- Prior art keywords
- neuropsychiatric diseases
- identifying persons
- mediated neuropsychiatric
- betahemolytic
- streptococci
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102100026445 A-kinase anchor protein 17A Human genes 0.000 abstract 1
- 101000718019 Homo sapiens A-kinase anchor protein 17A Proteins 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 238000009534 blood test Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/301—Anxiety or phobic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Image Processing (AREA)
- Image Analysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47303395A | 1995-06-06 | 1995-06-06 | |
| PCT/US1996/009743 WO1996039631A1 (en) | 1995-06-06 | 1996-06-06 | METHOD OF IDENTIFYING PERSONS SUSCEPTIBLE TO GROUP A β-HEMOLYTIC STREPTOCOCCI-MEDIATED NEUROPSYCHIATRIC DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE237139T1 true ATE237139T1 (de) | 2003-04-15 |
Family
ID=23877917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96918399T ATE237139T1 (de) | 1995-06-06 | 1996-06-06 | Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5866347A (de) |
| EP (1) | EP0846267B1 (de) |
| JP (1) | JP2001507440A (de) |
| AT (1) | ATE237139T1 (de) |
| AU (1) | AU697755B2 (de) |
| CA (1) | CA2222737A1 (de) |
| DE (1) | DE69627352D1 (de) |
| IL (1) | IL122426A (de) |
| NZ (1) | NZ310301A (de) |
| WO (1) | WO1996039631A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6884591B2 (en) * | 2001-06-25 | 2005-04-26 | The Cleveland Clinic Foundation | Peripheral marker of blood brain barrier permeability |
| US7144708B2 (en) * | 2001-06-25 | 2006-12-05 | The Cleveland Clinic Foundation | Markers of blood barrier disruption and methods of using same |
| US7508965B2 (en) * | 2004-06-01 | 2009-03-24 | Lumidigm, Inc. | System and method for robust fingerprint acquisition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743538A (en) * | 1985-04-17 | 1988-05-10 | The Rockefeller University | Test for rheumatic fever and monoclonal antibodies useful therefor |
-
1996
- 1996-06-06 EP EP96918399A patent/EP0846267B1/de not_active Expired - Lifetime
- 1996-06-06 NZ NZ310301A patent/NZ310301A/xx unknown
- 1996-06-06 AU AU61073/96A patent/AU697755B2/en not_active Ceased
- 1996-06-06 DE DE69627352T patent/DE69627352D1/de not_active Expired - Lifetime
- 1996-06-06 CA CA002222737A patent/CA2222737A1/en not_active Abandoned
- 1996-06-06 JP JP50197497A patent/JP2001507440A/ja not_active Ceased
- 1996-06-06 WO PCT/US1996/009743 patent/WO1996039631A1/en not_active Ceased
- 1996-06-06 IL IL12242696A patent/IL122426A/xx not_active IP Right Cessation
- 1996-06-06 AT AT96918399T patent/ATE237139T1/de not_active IP Right Cessation
-
1997
- 1997-04-08 US US08/833,653 patent/US5866347A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996039631A1 (en) | 1996-12-12 |
| IL122426A0 (en) | 1998-06-15 |
| CA2222737A1 (en) | 1996-12-12 |
| EP0846267A1 (de) | 1998-06-10 |
| AU697755B2 (en) | 1998-10-15 |
| MX9709776A (es) | 1998-10-31 |
| IL122426A (en) | 2001-01-11 |
| AU6107396A (en) | 1996-12-24 |
| EP0846267B1 (de) | 2003-04-09 |
| NZ310301A (en) | 1998-12-23 |
| US5866347A (en) | 1999-02-02 |
| JP2001507440A (ja) | 2001-06-05 |
| DE69627352D1 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69220871D1 (de) | Vorrichtung und Verfahren zur Auftrennung und Analyse von Vollblut | |
| DE69729473D1 (de) | Pharmazeutisch-genetische verfahren zur verwendung bei der behandlung von krankheiten des nervensystems | |
| DE69635174D1 (de) | Nichtinvasive Vorrichtung zur Blutuntersuchung | |
| DE3883701D1 (de) | Verfahren und Vorrichtung für multiplexierte Vektorquantifizierung. | |
| DE69009545D1 (de) | Verfahren zur Sprachanalyse und -synthese. | |
| DE69518834D1 (de) | Verfahren und Vorrichtung zur Bestimmung der Erythrozytensedimentationsrate | |
| EP0625774A3 (de) | Verfahren und Vorrichtung zur Sprachdetektion. | |
| DE3887644D1 (de) | Vorrichtung und Verfahren zur Identifizierung von Gerüchen. | |
| ATE244018T1 (de) | Herstellungb und verwendung eines spezifischen gaba-aalpha5 rezeptorligands zur behandlung der erkrankung von alzheimer | |
| ATE98773T1 (de) | Verfahren zur optischen analyse. | |
| DE69626683D1 (de) | Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten | |
| DE3767123D1 (de) | Verfahren zur bestimmung des haematokrit aus vollblut sowie vorrichtung zur durchfuehrung des verfahrens. | |
| DE58904662D1 (de) | Verfahren und vorrichtung zur glanzmessung. | |
| DE69510772D1 (de) | Verfahren zur quantifizierung von lbp in körperflüssigkeiten | |
| DE69333076D1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
| DE69614958D1 (de) | Gerät und Verfahren zur Detektion von Fingerabdruckmerkmalen | |
| DE69204157D1 (de) | Verfahren zur bestimmung von anti-rns-antikörpern. | |
| ATE237139T1 (de) | Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten | |
| FR2741518B1 (fr) | Appareil pour estimer les fonctions intellectuelles d'une personne | |
| DE69018840D1 (de) | Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes. | |
| FI910324A7 (fi) | Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi | |
| DE69021547D1 (de) | Vorrichtung und Verfahren zum Feststellen der Echtheit der Handschrift einer Person. | |
| DE69022192D1 (de) | Verfahren und Vorrichtung zur Randdickeabmessung eines Brillenglases. | |
| NO973823L (no) | Påvisning av antistoffproduksjon | |
| DE69431051D1 (de) | Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |